Amphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Amphastar Pharmaceuticals (NASDAQ:AMPH) Research Coverage Started at Bank of America theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) saw a significant decrease in short interest in October. As of October 31st, there was short interest totalling 2,500,000 shares, a decrease of 6.0% from the October 15th total of 2,660,000 shares. Currently, 6.9% of the company’s shares are sold short. Based on an average daily trading […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) is scheduled to be issuing its quarterly earnings data on Wednesday, November 8th. Parties interested in listening to the company’s conference call can do so using this link. Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) last issued its quarterly earnings results on Tuesday, August 8th. The company reported […]
Perigon Wealth Management LLC Has $274,000 Stock Position in Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.